Hopstem Closes First Series C Tranche

Company: Hopstem Biotechnology · Event Type: Deal and Financing · Product/Asset: hNPC01 · Subject: Stroke · Event Date: August 10, 2026 Summary Hopstem Biotechnology completed the first closing of a Series C financing to advance its iPSC-derived forebrain neural progenitor-cell platform. New investors include Tasly…